期刊文献+

长五聚蛋白3因子在炎性相关疾病中的作用 被引量:12

Role of long pentraxin 3 in inflammation-related diseases
下载PDF
导出
摘要 长正聚蛋白3(long pentraxin 3,PTX3)是一种与C反应蛋白(C-reactive protein,CRP)同属于长正五聚家族成员的新的典型急性期蛋白,参与到炎症、免疫、血管重塑、细胞凋亡等广泛生物效应中。炎性相关疾病是现代社会人群中普遍高发的疾病,如何预防和改善炎症状态,是目前临床上需要攻克的难题。与CRP相比,PTX3能更好地反映出局部炎症,且其生物结构更加稳定,便于检测,有望成为临床上用来对炎症反应进行诊断和治疗的更敏感的生物学指标。 Inflammatory disease is a common and high prevalence of disease in modern society. How to prevent the occurrence of inflammation and improve the inflammatory state is a difficult problem now. Long pentraxin 3 (PTX3) is a new type of acute phase protein, with C-reactive protein (CRP) belongs to the long family of pentamers. PTX3 is involved in inflammation, immunity, vascular remodeling, apoptosis and other biological effects in a wide range. Studies have shown that compared with CRP, PTX3 can more quickly respond to local inflammation, and its biological structure is more stable and easy to detect; it is expected to become more clinically sensitive biological indicators for the diagnosis and treatment of inflammatory response.
作者 喻亚萍 郝丽荣 YU Yaping;HAO Lirong(Second Department of Nephrology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China)
出处 《临床与病理杂志》 2018年第4期853-857,共5页 Journal of Clinical and Pathological Research
基金 国家自然科学基金(81570638)~~
关键词 长五聚蛋白3 炎症 免疫 疾病 long pentraxin 3 inflammation immune disease
  • 相关文献

参考文献1

二级参考文献11

  • 1袁志华,桑更生,崔勇.超声检测颈动脉对冠心病的预诊断价值[J].实用全科医学,2006,4(1):25-26. 被引量:10
  • 2屈正俊,骆勤正,彭丽春,房明昌.高敏C反应蛋白及脉压与老年高血压患者动脉粥样硬化相关性探讨[J].中华老年心脑血管病杂志,2007,9(1):20-22. 被引量:20
  • 3Alberti KG, Robert FR, Eckel H, et al. Third Report of the Na- tional Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002,106(25 ) :3143 - 3421.
  • 4Hansson GK, Zhou X, Tornquist E, et al. The role of adaptive im- munity in atherosclerosis. Ann N Y Acad Sci, 2000,902 : 53 - 62,62 - 64.
  • 5Araujo JA, Zhang M, Yin F. Heme oxygnase - 1, oxidation, in- flammation and atherosclerosis. Front Pharmacol, 2012,3 ( 1 ) : 119.
  • 6Witteman JCM, Hofman A, Bots ML, et al . Carotidintima - media thickness at different sites:relation to incident myocardial infarc- tion. Eur Heart J ,2002,23 (5) :934 - 940.
  • 7Riley WA. Carotidintima - media thickness : risk assessment and scanning protocol. Eur Heart J,2002,23 ( 5 ) : 916 - 918.
  • 8Williams JK, Sukhova GK, Herrington DM, et al. Pravastatin has cholesterol- lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coil Cardiol, 1998,31 (3) :684 - 691.
  • 9Danesh J, Wheeler JG, Hirschfield GM, et al. C - reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004,350 (14) :1387 - 1397.
  • 10Chambless LE, Heiss G, Folsom AR, et al. Association of coro- nary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987 - 1993. Am J Epidemiol, 1997,146 ( 6 ) : 483 - 494.

共引文献4

同被引文献120

引证文献12

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部